Semaglutide sits alongside Tirzepatide as one of the two highest-demand products in our entire metabolic-disease category, and the fact that it's available in both injectable and oral formulations gives distributors genuine flexibility in matching the product to what a specific market's patients and prescribers are most comfortable with — a distinction that directly affects which formulation a buyer should be ordering.
- Approved indications: Type 2 diabetes mellitus, chronic weight management in adults with obesity or overweight with weight-related conditions
- Mechanism: A GLP-1 receptor agonist that slows gastric emptying, increases insulin secretion in response to food, and reduces appetite through central nervous system pathways
- Formulation distinction: Available as once-weekly subcutaneous injection or once-daily oral tablet — clarifying which format a buyer needs is essential before quoting, since sourcing and pricing differ between the two
- Demand driver: Part of the broader global GLP-1/weight-management surge, alongside Tirzepatide, generating some of the highest enquiry volume across our entire product catalogue
- GI side effects: Nausea, vomiting, and constipation common during dose escalation, generally improving over time as the body adjusts
- Contraindication: Personal or family history of medullary thyroid carcinoma or MEN2 syndrome — a hard contraindication
- Pancreatitis risk: Patients should be counseled on symptoms and advised to seek care for severe abdominal pain
- Gallbladder disease: Increased risk, particularly with rapid weight loss
- Pregnancy: Not recommended
- Certification: WHO-GMP sourced manufacturing
- Batch-specific testing: Potency validated per batch
- Allocation management: Given the extremely high global demand for this drug category, we communicate realistic availability timelines upfront and prioritize securing consistent manufacturer allocation specifically for this SKU
| Document |
Included |
| Certificate of Analysis (COA) |
? Standard |
| Certificate of Origin (COO) |
? Standard |
| MSDS |
? Standard |
Stock status: Subject to allocation — confirm formulation, quantity, and destination for current availability | Quote turnaround: 24-48 hours given allocation checks
- Logistics: Cold-chain GDP export (2–8°C) for injectable; standard export logistics for oral formulation
- Coverage: Global export markets, with particularly high demand across nearly every region we serve
- Tracking: Full shipment tracking included
- Institutional buyers: Hospital and pharmacy distributor support, with proactive communication on allocation constraints given global demand
- Unregistered markets: Named-patient supply pathway available, subject to the same allocation limitations affecting the industry broadly
What is Semaglutide used for?
Treats type 2 diabetes and supports chronic weight management in adults with obesity or weight-related conditions.
Get Semaglutide price from a GMP-compliant Indian supplier — how?
Send required formulation, strength, quantity, and destination for a verified quote, noting current allocation availability.
Is it available as a tablet or only injection?
Both — Semaglutide is available as a once-weekly injectable pen or a once-daily oral tablet.
Why is availability sometimes limited?
Global demand for GLP-1 drugs currently outpaces manufacturer supply, so allocation-based availability applies industry-wide.
Who supplies Semaglutide from India?
WHO-GMP certified manufacturing partners with full export documentation.
